Antidepressants and treatment provided as second-line or very first treatments assist two thirds of individuals with anxiety, however the remaining third have treatment resistant depression (TRD).”Given these clients are people who have actually not responded to two previous treatment attempts and have actually been ill for an average of 7 years, to get such a substantial action rate and a fifth who have a sustained response is really motivating,” stated Professor Morriss.He adds: “Patients who responded to the treatment might remain relatively well compared to how they were previously, with as little as one or two treatments a year.”Reference: “Connectivity-guided periodic theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized regulated trial” by Richard Morriss, Paul M. Briley, Lucy Webster, Mohamed Abdelghani, Shaun Barber, Peter Bates, Cassandra Brookes, Beth Hall, Luke Ingram, Micheal Kurkar, Sudheer Lankappa, Peter F. Liddle, R. Hamish McAllister-Williams, Alexander ONeil-Kerr, Stefan Pszczolkowski, Ana Suazo Di Paola, Yvette Walters and Dorothee P. Auer, 16 January 2024, Nature Medicine.DOI: 10.1038/ s41591-023-02764-zThe research study was moneyed by an MRC and NIHR collaboration produced to support the examination of interventions with prospective to make a step-change in the promotion of health, treatment of illness and improvement of rehab or long-lasting care.
Antidepressants and treatment provided as second-line or first treatments assist 2 thirds of people with depression, but the remaining third have treatment resistant anxiety (TRD).”Given these patients are people who have not reacted to two previous treatment attempts and have actually been ill for an average of 7 years, to get such a considerable action rate and a fifth who have a sustained action is actually encouraging,” said Professor Morriss.He adds: “Patients who responded to the treatment might stay fairly well compared to how they were formerly, with as little as one or two treatments a year. The next obstacle is to make transcranial magnetic stimulation a standard and widely offered treatment choice for difficult to treat anxiety.”Reference: “Connectivity-guided periodic theta burst versus repeated transcranial magnetic stimulation for treatment-resistant depression: a randomized regulated trial” by Richard Morriss, Paul M. Briley, Lucy Webster, Mohamed Abdelghani, Shaun Barber, Peter Bates, Cassandra Brookes, Beth Hall, Luke Ingram, Micheal Kurkar, Sudheer Lankappa, Peter F. Liddle, R. Hamish McAllister-Williams, Alexander ONeil-Kerr, Stefan Pszczolkowski, Ana Suazo Di Paola, Yvette Walters and Dorothee P. Auer, 16 January 2024, Nature Medicine.DOI: 10.1038/ s41591-023-02764-zThe study was moneyed by an MRC and NIHR collaboration produced to support the evaluation of interventions with prospective to make a step-change in the promo of health, treatment of disease and enhancement of rehabilitation or long-term care.
